Ascletis Advances ASC30: A New Oral GLP-1 Contende...
Category : Clinical Trial Update 29 April 2026The race to dominate the GLP-1 market is intensifying. And oral formulations are the next battlegrou...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Paradigm Health and FDA Pilot a Real-Time Clinical...
Category : Clinical Trial Update 29 April 2026Clinical trials have a speed problem. They are slow, expensive, and burdened by fragmented data flow...
Cirius Therapeutics Targets Postpartum Diabetes Ri...
Category : Clinical Trial Update 29 April 2026A major gap in metabolic care often begins after pregnancy. Women with gestational diabetes mellitus...
Novartis Secures EU Approval for Rhapsido: A New O...
Category : Approval/Launch 28 April 2026The treatment landscape for chronic spontaneous urticaria (CSU) just shifted. Novartis has secured E...
AbbVie Files for Subcutaneous Induction of SKYRIZI...
Category : Clinical Trial Update 28 April 2026AbbVie has submitted a new application to the U.S. Food and Drug Administration seeking approval for...
Latest Newsletter Post
-
Cirius Therapeutics Targets Postpar..
29 April 2026
-
Paradigm Health and FDA Pilot a Rea..
29 April 2026
-
Ascletis Advances ASC30: A New Oral..
29 April 2026
-
Johnson & Johnson’s IMAAVY Secures..
28 April 2026
-
AbbVie Files for Subcutaneous Induc..
28 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com